Functional CRISPR Screens Define Genetic Drivers for Cancer Transformation and Progression from Non-Cancerous Cells
International Journal of Molecular Sciences · 02.04.2026 · 27 (7) · 3223
DOI: 10.3390/ijms27073223 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.04.2026. Verfasst von Shixin Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 1…. Hauptthemen laut MEDLINE: Cell Transformation, Neoplastic, CRISPR-Cas Systems, Liver Neoplasms, Breast Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China, the 111 Project.
Abstract (Originalsprache)
Tumor initiation and metastatic progression are driven by context-dependent genetic alterations that disrupt tumor suppressor pathways, metabolic homeostasis, and signaling networks. However, the initial drivers that transform normal cells into malignant ones and their context dependency remain elusive. To address this, we aimed to systematically identify and characterize these drivers across cancer types, species, and microenvironments. We constructed customized clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) knockout (KO) libraries targeting high-frequency mutated and downregulated genes associated with liver hepatocellular carcinoma (LIHC) and breast carcinoma (BRCA) and conducted parallel functional screens in non-cancerous mouse and human fibroblast cell lines under two-dimensional (2D), three-dimensional (3D), and in vivo conditions. Strikingly, TP53 and NF1 emerged as pan-context drivers consistently enriched across immortalization, tumorigenesis, and metastasis in both LIHC and BRCA settings, while most other identified drivers were largely species-, tissue-, and microenvironment-specific with limited cross-model overlap. Despite this heterogeneity, all drivers converge on core pathways including epigenetic regulation, metabolic reprogramming, and growth factor signaling. Unlike prior studies on established cancer cells, this work defines the genetic barriers restricting the malignant transformation of primary normal cells, offering a new framework for early cancer evolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China.
- Foshan Graduate School of Innovation, Northeastern University, Foshan 528311, China.
- National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China.
- Key Laboratory of Data Analytics and Optimization for Smart Industry (Northeastern University), Ministry of Education, Shenyang 110819, China.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- the 111 Project
- the Construction Project of Liaoning Provincial Key Laboratory, China
- 111 Project
- Construction Project of Liaoning Provincial Key Laboratory, China
Zitieren
APA
Ma, S., Li, Y., & Fei, T. (2026). Functional CRISPR Screens Define Genetic Drivers for Cancer Transformation and Progression from Non-Cancerous Cells. International Journal of Molecular Sciences, 27(7), 3223. https://doi.org/10.3390/ijms27073223
Vancouver
Ma S, Li Y, Fei T. Functional CRISPR Screens Define Genetic Drivers for Cancer Transformation and Progression from Non-Cancerous Cells. International Journal of Molecular Sciences. 2026;27(7):3223. doi:10.3390/ijms27073223
BibTeX
@article{Ma2026,
author = {Ma, Shixin and Li, You and Fei, Teng},
title = {Functional CRISPR Screens Define Genetic Drivers for Cancer Transformation and Progression from Non-Cancerous Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3223},
doi = {10.3390/ijms27073223}
}
EUVIMED